Ghana's Human Immunodeficiency Virus (HIV) prevalence has declined significantly to 1.5 percent, marking substantial progress from 2.5 percent recorded two decades ago, according to...
Gilead Sciences has secured US approval for Yeztugo, a groundbreaking twice-yearly injection to prevent HIV, but its $28,000 annual price is raising alarms.
The drug,...
President John Dramani Mahama has described rising HIV rates among young Ghanaians as a "troubling and avoidable" national crisis requiring urgent action.
Speaking at Ghana’s...
Ghana’s First Lady, Lordina Mahama, has issued a strong appeal to young citizens to embrace early health testing and regular checkups, emphasizing their critical...
The U.S. Food and Drug Administration has granted historic approval to the world's first twice-yearly injectable HIV prevention treatment, a development poised to transform...